Journal Logo

Poster Session I: Myeloma and other monoclonal gammopathies – Clinical

PF588 SIGNIFICANT POM EFFECT ON THE IMMUNE-CELL PROFILES IN B, T AND NK SUBSETS IN A LARGE COHORT CLINICAL TRIAL IN RELAPSED/REFRACTORY MYELOMA

Prabhala, R.1; Samur, M.2; Talluri, S.1; Stekla, M.1; Acharya, S.1; Yenumula, C.1; Nanjappa, P.1; Lopez, M.1; Buonopane, M.3; Heubeck, A.3; Fulciniti, M.1; Szalat, R.1; Lazo-Kallanian, S.3; Hong, K.4; Peluso, T.4; Daley, J.1; Biyukov, T.4; Rocafiguera, A. Oriol5; Beksac, M.6; Dimopoulos, M.7; Hussain, M.4; Pierceall, W.4; Richardson, P.8; Anderson, K.1; Thakurta, A.4; Avet-Loiseau, H.9; Munshi, N.10

Author Information
doi: 10.1097/01.HS9.0000560640.62389.e5
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.